Departamento de Ciencias Farmacéuticas y de la Salud, Facultad de Farmacia, Universidad CEU-San Pablo, 28668 Madrid, Spain.
Institute of Vascular Medicine, Chinese University of Hong Kong, 20001 Hong Kong, China; Li Ka Shing Institute of Health Sciences, Chinese University of Hong Kong, 20001 Hong Kong, China.
Trends Endocrinol Metab. 2015 Jul;26(7):367-75. doi: 10.1016/j.tem.2015.04.003. Epub 2015 May 22.
Perivascular adipose tissue (PVAT) releases several important vasoactive factors with physiological and pathophysiological paracrine effects. A large body of evidence suggests regional phenotypic and functional differences among PVAT depots, depending on the specific vascular bed or different regions in the vascular bed where the PVAT is located. These non-uniform and separate PVATs exert various paracrine effects on vascular structure and function that largely impact disease states, such as endothelial dysfunction, atherosclerosis, or insulin resistance. This emerging view of PVAT function requires considering heterogeneous PVAT as a specialized organ that can differentially regulate vascular function depending on its anatomical location. In this context, the adipose-vascular axis may represent a novel target for pharmacological intervention in vasculopathy in cardiometabolic disorders.
血管周脂肪组织 (PVAT) 释放多种具有生理和病理旁分泌作用的重要血管活性因子。大量证据表明,PVAT 隔室之间存在区域性表型和功能差异,这取决于 PVAT 所在的特定血管床或血管床的不同区域。这些非均匀和独立的 PVAT 对血管结构和功能发挥各种旁分泌作用,这些作用在很大程度上影响疾病状态,如内皮功能障碍、动脉粥样硬化或胰岛素抵抗。这种新兴的 PVAT 功能观点需要将异质的 PVAT 视为一种特殊的器官,根据其解剖位置差异调节血管功能。在这种情况下,脂肪-血管轴可能代表代谢性心血管疾病血管病变中药物干预的新靶点。